New diabetes drug study aims to improve blood sugar control safely

NCT ID NCT05164263

Recruiting now Disease control Sponsor: Getz Pharma Source: ClinicalTrials.gov ↗

First seen Jan 31, 2026 · Last updated May 08, 2026 · Updated 8 times

Summary

This study looks at how safe and effective the drug empagliflozin (taken with or without metformin) is for adults with type 2 diabetes. About 156 participants in Pakistan will take the drug and be monitored for side effects and blood sugar changes over 6 months. The goal is to see if this treatment helps control diabetes with acceptable risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Agha Khan univeristy hospital
RECRUITING

Nairobi, Kenya, Kenya

Contact
Kabul University of Medical Sciences(KUMS)
COMPLETED

Kabul, Afghanistan, Afghanistan
Lagos University Teaching Hospital
RECRUITING

Lagos, Nigeria, Nigeria

Contact

Contact

Contact
NHK
COMPLETED

Kandy, Kandy, Sri Lanka
National hospital Sri Lanka
COMPLETED

Colombo, Colombo, Sri Lanka
Umar Diabetes Foundation
COMPLETED

Islamabad, Pakistan

Conditions

Explore the condition pages connected to this study.

EFFICACY, SELF SAFETY ISSUES TYPE II DIABETES MELLITUS TYPE II DIABETES MELLITUS